2026年11月4日星期三
M
Panorama Universal
Notícias globais
Mitsui Chemicals to buy Japan chip material maker JSR for over $8.2bn— 日经 Nikkei AsiaPetrovietnam CEO sees a future of nuclear and wind power— 日经 Nikkei AsiaTaiwan airlines continue flights over Russia, rattling Europeans— 日经 Nikkei AsiaDebt costs curb growth for developing nations, Rockefeller official says— 日经 Nikkei AsiaChina's Temu, JD.com revamp business models amid tariff headwinds— 日经 Nikkei AsiaNidec's rise and fall fuels calls for sweeping overhaul of Japanese company— 日经 Nikkei AsiaAPEC host China to keep cars off street, close schools during Shenzhen summit— 日经 Nikkei AsiaJapan regional banks form united front on cybersecurity— 日经 Nikkei AsiaMitsui Chemicals to buy Japan chip material maker JSR for over $8.2bn— 日经 Nikkei AsiaPetrovietnam CEO sees a future of nuclear and wind power— 日经 Nikkei AsiaTaiwan airlines continue flights over Russia, rattling Europeans— 日经 Nikkei AsiaDebt costs curb growth for developing nations, Rockefeller official says— 日经 Nikkei AsiaChina's Temu, JD.com revamp business models amid tariff headwinds— 日经 Nikkei AsiaNidec's rise and fall fuels calls for sweeping overhaul of Japanese company— 日经 Nikkei AsiaAPEC host China to keep cars off street, close schools during Shenzhen summit— 日经 Nikkei AsiaJapan regional banks form united front on cybersecurity— 日经 Nikkei Asia

Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial

Fonte Nature 医学研究Há 2 dias
Resumo do conteúdo

Este site fornece apenas o título e o índice do resumo; o conteúdo completo e os direitos autorais pertencem ao publicador original. Clique no link do texto original para ler.

Ir para o texto original
Canal de origem
Saúde
Região de origem
Perspetiva global
Idioma do texto original
English
Número do item
health-5750ab15

Comments 0 comments

No comments yet. Be the first.

Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial · Panorama Universal